ArticleOncology research2016

Inhibition of NF-κB Activity Enhances Sensitivity to Anticancer Drugs in Cholangiocarcinoma Cells.

Wunchana Seubwai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.